menu
    • menu

    Company profile for Hyloris Pharmaceuticals

    NEW Drugs in Dev: 11
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hyloris is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. We unlock the untapped potentials of existing medications to create new and improved treatment options. We develop innovative proprietary products that offer significant advantages compared to currently available alternatives. Our aim is to address the unmet medical needs of pa...
    Hyloris is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. We unlock the untapped potentials of existing medications to create new and improved treatment options. We develop innovative proprietary products that offer significant advantages compared to currently available alternatives. Our aim is to address the unmet medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hyloris PharmaceuticalsBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Boulevard Gustave Kleyer 17, 4000 Liège,
    Telephone
    Telephone
    +32 (0)4 346 02 07
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hyloris.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hyloris-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Manufacturing Issues Prompt FDA Rejection Of Hyloris Antiviral
    Manufacturing Issues Prompt FDA Rejection Of Hyloris Antiviral

    13 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fda-fires-another-manufacturing-related-crl-one-hyloris

    FIERCE PHARMA
    13 Mar 2026
    Share Share
    RedHill Biopharma's 2024 Financial Results and Highlights
    RedHill Biopharma's 2024 Financial Results and Highlights

    10 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-announces-full-year-2024-financial-results-and-operational-highlights-302425587.html

    PR NEWSWIRE
    10 Apr 2025
    Share Share
    Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
    Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

    14 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/14/2845976/0/en/Hyloris-Reports-Full-Year-Results-for-2023-Provides-Business-Outlook.html

    GLOBENEWSWIRE
    14 Mar 2024
    Share Share
    Communication at the request of the FSMA on the transactions with Qliniq
    Communication at the request of the FSMA on the transactions with Qliniq

    14 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/14/2845961/0/en/Communication-at-the-request-of-the-FSMA-on-the-transactions-with-Qliniq.html

    GLOBENEWSWIRE
    14 Mar 2024
    Share Share
    Hyloris to Report 2023 Full-Year Results on 14 March 2024
    Hyloris to Report 2023 Full-Year Results on 14 March 2024

    08 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/08/2842882/0/en/Hyloris-to-Report-2023-Full-Year-Results-on-14-March-2024.html

    GLOBENEWSWIRE
    08 Mar 2024
    Share Share
    Hyloris Enrolls First Patient in Phase 3 Trial for its Proprietary Mouth Rinse
    Hyloris Enrolls First Patient in Phase 3 Trial for its Proprietary Mouth Rinse

    14 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/14/2829330/0/en/Hyloris-Enrolls-First-Patient-in-Phase-3-Clinical-Trial-for-its-Proprietary-Mouth-Rinse-to-Control-Incidences-of-Bleeding-Related-to-Dental-Procedures.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search